A genetic bleeding disorder, haemophilia worsens quality of life, can cause deformities and disabilities and in the worst of ...

The petition was filed by Prema Ram who appeared in the Civil Services Examination conducted by the Union Public Service Commission (UPSC) in May this year ...

CSL Behring Germany today announced that the first haemophilia B patient in Germany was treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at the Hemophilia Treatment Center at ...

The first haemophilia B patient in Germany has been treated with the one-time gene therapy HEMGENIX at the Hemophilia Treatment Center at Hannover Medical School, CSL Behring Germany has announced.

Scientists from the Centenary Institute and the University of Sydney have made a landmark discovery that could lead to safer ...

Pfizer has shared positive top-line results from a late-stage study of its haemophilia A and B therapy Hympavzi (marstacimab). The phase 3 BASIS trial has been evaluating the drug in adult and ...

CSL’s Hemgenix addresses the underlying genetic cause of haemophilia B by enabling the body to continuously produce FIX, and is the only one-time gene therapy to be approved in the UK for adults with ...

The President was seen wearing what looked to be concealer on his hand to hide his apparent bruising on Tuesday, in the latest incident to spark concerns over the Presidents health.

About haemophilia Haemophilia is a rare inherited bleeding disorder that impairs the body's ability to make blood clots, a process needed to stop bleeding 4.